Our researchers and clinicians discover and develop innovations that impact patient health
TIDO guides our researchers and clinicians through the commercialization process.Disclose an Invention
We are a preferred development partner for the life science industry across the globe
TIDO establishes strong research and development partnerships with life science companies at all stages of development.Partner with Us
BioMarin is a world leader in developing and commercializing first-in-class and best-in-class innovative biopharmaceuticals for rare diseases driven by genetic causes. BioMarin’s mission is to bring new treatments to market that will make a big impact on small patient populations. We are inviting scientists to submit short proposals to join our efforts in advancing treatments for rare diseases.
Proposals are due February 1, 2022.
Catch up on TIDO’s accomplishments in FY2020 with our annual report, available online along with our reports since 2015.
Are you an innovator at Boston Children’s Hospital? Curious about what TIDO does? Learn about how to commercialize your research and how we can help in our Inventor’s guide.
Learn more about our updated Material Transfer Agreement (MTA) process, which includes a new self-serve outbound MTA and questionnaire forms for other requests.
Discover the diversity of technologies available for partnering at Boston Children’s Hospital.